Better TherapeuticsBTTX
13F holders, Q1 2024 (March 31)3holders
$0.01avg. 13F price*
At the end of Q1 2024, 3 institutions reported holding Better Therapeutics Inc. (BTTX) in their 13F filings. The largest holders were Capital Investment Advisory Services, LLC ($994), XTX Topco Ltd ($457) and Aspire Private Capital, LLC ($3).
- Company
- Better Therapeutics Inc.
- CUSIP
- 08773T104
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 20 | $265K |
Ownership 3 holders
| Capital Investment Advisory Services, LLC | 0.00% | No change | 71,000 | $994 |
| XTX Topco Ltd | 0.00% | Add +125.8% | 32,670 | $457 |
| Aspire Private Capital, LLC | 0.00% | No change | 200 | $3 |
"% of holder's portfolio" is BTTX's weight in each manager's 13F, not the share of Better Therapeutics Inc. the manager owns.